New York birth injury attorneys reached a settlement agreement in a birth injury lawsuit for an amount of $4,320,000. The claim alleged defendants failed to deliver the injured infant in a timely manner, resulting in serious birth injuries. The case centered on a child who was born on January 24, 2006 at the Sound Shore…
Read More
The Food and Drug Administration (FDA) recently announced plans to hold a two-day expert advisory panel meeting in June to address mounting concerns about the safety of metal-on-metal hip implants. Hip replacement surgery is a common surgical procedure intended to provide increased patient mobility and alleviate pain associated with joint problems, including arthritis. According to…
Read More
In a recent editorial piece, the New York Times articulated what injured victims and plaintiffs lawyers have been saying for the last year – Congress should not allow generic drug manufacturers special protections when those manufacturers fail to warn patients of the generic drug’s dangers. Last year, the United States Supreme Court ruled that although…
Read More
According to a recent Bloomberg article, a study found that the recalled St. Jude Medical Inc. (“St. Jude”) wires, still in use to connect life-saving defibrillators to the hearts of 79,000 patients, had multiple defects that led to melted conductors, electrical abnormalities, and shocks. St. Jude stopped selling its Riata wires in December 2010, and…
Read More
The United States Food & Drug Administration (FDA) has announced an urgent recall of Brilliant Blue G, distributed by Franck’s Compounding Lab in Ocala, Florida. The recall has issued on March 9, 2012. According to the recall notice, Brilliant Blue G has been associated with fungal infections of the eye. According to the pharmacy, lots…
Read More